Disparities in α 1 -Antitrypsin Deficiency Testing and Treatment in US Adults - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Differences in α1-Antitrypsin Deficiency Testing and Treatment Among US Adults

  • By

  • Arianne K. Baldomero

  • Lisa Smith

  • Amy Gravely

  • Vickram Tejwani

  • Chris H. Wendt

  • October 15, 2026

Share

  • 1

    α1-Antitrypsin deficiency is an inherited disorder associated with lung and liver disease and remains underdiagnosed, in part because testing is infrequent.

  • 2

    The study examined α1-antitrypsin deficiency testing among US veterans with COPD, asthma, asthma-COPD overlap, or spirometry-confirmed airflow obstruction.

  • 3

    The retrospective cohort used national Veterans Affairs electronic health records for patients with at least 2 COPD and/or asthma encounters from January 2000 through December 2024.

  • 4

    Testing was defined as at least 1 serum α1-antitrypsin measurement or genotype analysis during the study period.

  • 5

    The study also assessed augmentation therapy prescriptions among patients classified as having α1-antitrypsin deficiency and examined characteristics associated with testing and treatment.

Original Source(s)

Related Content